31
Participants
Start Date
August 1, 2013
Primary Completion Date
June 16, 2016
Study Completion Date
May 31, 2018
Telbivudine
CHB patients who are receiving adefovir or tenofovir disoproxil fumarate are recruited. At the time of recruitment (0 month, baseline), lamivudine is switched to telbivudine while adefovir or tenofovir disoproxil fumarate was continued. The patients are followed-up for 24 months.
Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
The University of Hong Kong
OTHER